Home / Resource Library / Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemia

Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemia

Study investigated complete response as a surrogate endpoint in clinical trials for CLL.